The nosology and neuropathology of human conditions related to unconventional infectious agents or prions

European Journal of Neurology

Volumn 3, Issue 6, 1996, Pages 487-499

  Hauw, J J ^a   Sazdovitch, V ^a   Seilhean, D ^a   Camilleri, S ^a   Lazarini, F ^a   Delasnerie Laupretre N ^a   Duyckaerts, C ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Creutzfeldt; Human spongiform encephalopathies; Jakob disease; Neuropathology; Prion diseases; Slow virus diseases

Indexed keywords

BRAIN SPONGIOSIS; CREUTZFELDT JAKOB DISEASE; DISEASE CLASSIFICATION; HUMAN; NEUROPATHOLOGY; PRION DISEASE; PRIORITY JOURNAL; REVIEW; SLOW VIRUS DISEASE;

EID: 0029953481     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1468-1331.1996.tb00263.x     Document Type: Review

References (128)

1. Amouyel P, Vidai O, Launay JM and Laplanche JL, for the French Research Group on Epidemiology of human spongiform encephalopathy (1994) The Apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet, 344, 1315-1318.
2. Anderson R (1971) Histopathology of the brain in kuru. VIe Congrès International de Neuropathologie. Paris, Masson.
3. Barcikowska M, Liberski P, Boellaard J, Brown P, Gajdusek D and Budka H (1993) Microglia is a component of the prion protein amyloid plaque in the Gerstmann-Sträussler-Scheinker syndrome. Acta Neuropathologica (Berlin), 85, 623-627.
4. Beck E, Bak IJ, Christ JF, Gajdusek DC, Gibbs CJJ and Hassler R (1975) Experimental kuru in the spider monkey, histopathological and ultrastructural studies of the brain during early stages of incubation. Brain, 98, 595-612.
5. Beck E and Daniel PM (1971) Subacute degenerations of the brain transmissible to experimental animals: a neuropathological evaluation. VIe Congrès International de Neuropathologie. Paris, Masson.
6. Billette de Villemeur T, Deslys J, Pradel A, Soubrie J, Alpérovitch A, Tardieu M, Rochiccioli P, Chaussain J, Hauw J, Dormont D and Agid Y (1996) The high incidence of extractive hormone induced Creutzfeldt-Jakob disease in France. Neurology (in press).
7. Boellaard JW and Schlote W (1980) Subakute spongiforme Encephalopathie mit multiformer Plaquebildung. Acta Neuropathologica, 49, 205-212.
8. Brion J, Fraser H, Flament-Durand J and Dickinson A (1987) Amyloid scrapie plaques in mice and Alzheimer senile plaque share common antigen with tau, a microtubule-associated protein. Neuroscience Letters, 78, 115-118.
9. Brion S, Krespi Y and Seilhean D (1993) Athymormie progressive chez une femme de 30 ans. Revue Neurologique (Paris), 149, 815-819.
10. Brion S, Masse G and Plas J (1983) Histopathologie de la spongiose dans la maladie de Creutzfeldt-Jakob et dans les démences séniles et préséniles. In: Virus non conventionnels et Affections du Systeme Nerveux Central. (Eds L Court and F Cathala), pp. 227-234, Paris, Masson.
11. Broswnell B and Oppenheimer DR (1965) An ataxic form of subacute presenile polio-encephalopathy (Creutzfeldt-Jakob disease). Journal of Neurology Neurosurgery and Psychiatry, 37, 195-200.
12. Brown P (1992) Expression phénotypique des différences mutations dans l'encephalopathie spongiforme humaine transmissible. Revue Neurologique (Paris), 148, 317-327.
13. Brown P (1994) Transmissible human spongiform encephalopathy (infectious cerebral amyloidosis): Creutzfeldt-Jakob disease, Gerstmann-Sträussler-Scheinker syndrome, and kuru. In: Neurodegenerative Diseases, (Ed DB Calne) pp 839-877 Philadelphia, Saunders.
14. Brown P, Cathala F, Castaigne P and Gajdusek DC (1986) Creutzfeldt-Jakob disease: clinical analysis of a consecutive series of 230 neuropathologically verified cases. Annals of Neurology, 20, 597-602.
15. Brown P, Preece MA and Will RG (1992) "friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob disease. Lancet, 340, 24-27.
16. Bruton C, Bruton R, Gentleman S and Roberts G (1995) Diagnosis and incidence of Prion (Creutzfeldt-Jakob) disease: a retrospective archival survey with implication for future research. Neurodegeneration, 4, 357-368.
17. Buchanan C, Preece M and Milner R (1991) Mortality, neoplasia, and Creutzfeldt-Jakob disease in patients treated with human pituitary growth hormone in the United Kingdom. British Medical Journal, 302, 824-828.
18. Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Collinge J, Diringer H, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Kretzschmar HA, Lantos PL, Masullo C, Pocchiari M, Schlote W, Tateishi J and Will RG (1995a) Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathology, 5, 319-322.
19. Budka H, Aguzzi A, Brown P, Brucher J-M, Bugiani O, Gullotta F, Haltia M, Hauw J-J, Ironside JW, Jellinger K, Kretzschmar HA, Lantos PL, Masullo C, Schlote W, Tateishi J and Weller RO (1995b) Neuropathological diagnostic criteria for Creutzfeldt-Jakob (CJD) and other human spongiform encephalopathies (prion diseases). Brain Pathology, 15, 319-322.
20. Buggiani O, Tagliavini F, Giaccone R and Boeri R (1986) Creutzfeldt-Jakob disease: astrocytosis and spongiform changes of the white matter. In: Unconventional Virus Diseases of the Central Nervous System. (Eds LA Court, D Dormons, P Brown and D T Kimberline). Fontenay-aux-Roses, CEA.
21. Buggiani O, Giaccone G, Verga L, Pollo B, Frangione B, Farlow MR, Tagliavini F and Ghetti B (1993) βPP participates in PrP-amyloid plaques of Gerstmann-Straussler-Scheinker disease, Indiana Kindred. Joural of Neuropathology and Experimental Neurology, 52, 64-70.
22. Castellani R, Parchi P, Stahl J, Capellari S, Cohen M and Gambetti P (1996) Early pathologic and biochemical changes in Creutzfeldt-Jakob disease: study of brain biopsies. Neurology, 46, 1690-1693.
23. Cathala F, Court L, Hauw J-J, Escourolle R, Rohmer F and Castaigne P (1975) Clinical studies in primates inoculated with Kuru and Creutzfeldt-Jakob agents. In Advances in Neurology, 10, 319-339 (Eds ES Meldrum and CD Marsden), Raven Press, New York.
24. Chazot G, Broussolle E, Lapras C, Blätter T, Aguzzi A and Kopp N (1996) New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet, 347, 1181.
25. Collinge J and Palmer M (1991) CJD discrepancy. Nature, 353, 802.
26. Collinge J, Brown J, Hardy J, Mullan M, Rossor M, Baker H, Crow T, Lofthouse R, Poulter M, Ridley R, Owen F, Bennett C, Dunn G, Harding A, Quinn N, Doshi B, Roberts G, Honavar M, Janota I and Lantos P (1992) Inherited prion disease with 144 base pair gene insertion. II. Clinical and pathological features. Brain, 115, 687-710.
27. Collinge J, Owen F, Poulter M, et al. (1990) Prion dementia without characteristic pathology. Lancet, 336, 7-9.
28. Connolly J, Allen I and Dermott E (1988) Transmissible agent in the amyotrophic form of Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery and Psychiatry, 51, 1459-1460.
29. Créange A, Gray F, Cesaro P, Adle-Biassette H, Duvoux C, Cherqui D, Bell J, Parchi P, Gambetti P and Degos J (1995) Creutzfeldt-Jakob disease after liver transplantation. Annals of Neurology, 38, 269-272.
30. Cuillé J and Chelle P (1936) La maladie dite tremblante du mouton est-elle inoculable? Cantes rendus de l'Academie des Sciences (Paris), 203, 1552-1554.
31. Davies P, Janfar S, Ferguson I and Windl O (1993) Creutzfeldt-Jakob disease in individual occupationally exposed to BSE. Lancet, 342, 680.
32. Delisle MB, Fabre N, Rochiccioli R, Doerr-Schott J, Rumeau, J-L, Bes A (1993) Maladie de Creutzfeldt-Jakob après traitement par l'hormone de croissance extractive humaine. Etude clinico-pathologique. Revue Neurologique (Paris), 149, 524-527.
33. De Silva R, Ironside J, McCardle L, Esmonde T, Bell J, Will R, Windl O, Dempster M, Estibeiro P and Lathe R (1994) Neuropathological phenotype and "prion protein" genotype correlation in sporadic Creutzfeldt-Jakob disease. Neuroscience Letters, 179, 50-52.
34. Deslys J, Lasmezas C and Dormont D (1994) Selection of specific strains in iatrogenic Creutzfeldt-Jakob disease. Lancet, 343, 848-849.
35. Dickson D, Lee S, Mattiace L, Yen S and Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia, 7, 75-83.
36. Diringer H (1992) Hidden amyloidoses. Experimental and Clinical Immunogenetics, 9, 212-229.
37. Doh-ura K, Kitamoto T, Sakasi Y and Tateishi J (1991) CJD discrepancy. Nature, 353, 801-802.
38. Duffy P, Wolf J, Collins G, DeVoe A, Streeten B and Cowen D (1974) Possible person-to-person transmission of Creutzfeldt-Jakob disease. New Engl and Journal of Medicine, 290, 692.
39. Foncin J (1967) Etude ultrastructurale de la maladie de Creutzfeldt-Jakob. Acta Neuropathologica Berlin (Supplement 3), 127-130.
40. Foncin J, Gaches J, Cathala F, El Sherif E and Lebeau J (1980) Transmission iatrogene interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Revue Neurologique (Paris), 136, 280.
41. Fradkin J, Schoenberger L, Mills J, Gunn W, Piper J, Wysowski D, Thomson R, Durako R and Brown P (1991) Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States. JAMA, 265, 880-884.
42. Gajdusek DC (1977) Unconventional viruses and the origin and disappearance of Kuru. Science, 197, 943-960
43. Gajdusek D (1988) Transmissible and non transmissible dementias: distinction between primary cause and pathogenetic mechanism in Alzheimer's disease and aging. Mount Sinai Journal of Medicine, 55, 3-5.
44. Gajdusek D (1996) Infectious amyloids: subacute spongiform encephalopathies as transmissible cerebral amyloidoses. In: Fields Virology, pp. 2851-2900. Philadelphia, PA, Lippincott-Raven.
45. Gajdusek DC (1990) Subacute Spongiform Encephalopathies: transmissible cerebral amyloidoses caused by unconventional viruses, In Virology (Eds BN Fields and DM Knipe), pp. 2289-2324. New York, Raven Press.
46. Gajdusek DC, Beyreuther K, Brown P, Cork L, Cunnigham D, Frangione B, Gibbs C, Goldfarb L, Goldgaber D and Hsiao K (1991) Regulation and genetic control of brain amyloid. Brain Research Reviews, 16, 83-114.
47. Gajdusek DC, Gibbs CJ Jr and Alpers M (1966) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature, 209, 794-796.
48. Garcin R, Brion S and Knochneviss A (1963) Le syndrome de Creutzfeldt-Jakob et les syndromes cortico-striés du presenium. Revue Neurologique (Paris), 109, 419-441.
49. Gambetti P, Parchi P, Petersen R, Chen S and Lugaresi E (1995) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: clinical, pathological and molecular features. Brain Pathology, 5, 43-51.
50. Genthon R, Gray F, Salama J, Duyckaerts C, Belin C, Brucher J, Baron H and Delaporte P (1992) Maladie de Gerstmann-Sträussler-Scheinker. Etude pathologique et généalogique. Revue Neurologique (Paris), 148, 335-342.
51. Gerstmann J, Strèussler E and Scheinker I (1936) Über eine eigenartige hereditèr-familière Erkrankung des Zentralnervensystems Zugleich ein Beitrag zur Frage des vorzeitigen lokalen Alterns. Zeitschrift für Neurologique, 154, 736-762.
52. Ghetti T, Tagliavini F, Masters C, Beyreuter K, Giaccone G, Verga L, Farlow M, Conneally P, Dlouhy S, Azzarelli B and Bugiani O (1989) Gerstmann-Sträussler-Scheinker disease. II. Neurofibrillary tangles and plaques with PrP-amyloid coexist in the same family. Neurology, 39, 1453-1461.
53. Ghetti T, Piccardo P, Spillanti M, Ichimiya Y, Porro M, Perini F, Kitamoto T, Tayeishi J, Seiler C, Giaccone G, Frangione B, Bugiani O, Giaccone G, Prelli F, Godert M, Dlouhy S and Tagliavini F (1996) Vascular variant of prion protein cerebral amyloidosis with t-positive neurofibrillary tangles : the phenotype of the top codon 145 mutation in PRNP. Proceedings of the National Academy of Science, U.S.A., 93, 744-748.
54. Gibbs C, Joy A, Heffner R, Franko M, Miyazaki M, Asher D, Parisi J, Brown P and Gajdusek D (1985) Clinical and pathological features and laboratory confirmation of Creutzfeldt-Jakob disease in a recipient of pituitary-derived human growth hormone. New England Journal of Medicine, 313, 734-738.
55. Goldfarb LG, Petersen RB, Tabaton M, Brown P, Leblanc A, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, MacKeever PE, Morani L, Schrank B, Swergold GD, Autilio-Gambetti L, Gajdusek C, Lugaresi E and Gambetti P (1992) Fatal insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science, 258, 806-808.
56. Gorman DG, Benson DF, Vogel DG and Vinters HV (1992) Creutzfeldt-Jakob disease in a pathologist. Neurology, 42, 463.
57. Guiroy DC, Shankar SK, Gibbs CJ, Messenheimer JA, Das S, D.C. G (1989) Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfeldt-Jakob disease. Annals of Neurology, 25, 102-106.
58. Guiroy D, Wakayama I, Liberski P and Gajdusek D (1994) Relationship of microglia and scrapie amyloid-immunoreactive plaques in kuru, Creutzfeldt-Jakob disease and Gerstmann-Sträussler syndrome. Acta Neuropathological (Berlin), 87, 526-530.
59. Guiroy D, Yanagihara R and Gajdusek D (1991) Localization of amyloidogenic proteins and sulfatated glycosaminoglycans in non transmisible and transmissible cerebral amyloidoses. Acta Neuropathological (Berlin), 82, 87-92.
60. Hadlow WJ (1959) Scrapie and kuru. Lancet, 2, 289-290.
61. Hayward PAR, Bell JE and Ironside JW (1994) Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease. Neuropathology and Applied Neurobiology, 20, 375-383.
62. Heidenhain A (1929) Klinische und anatomische Undersuchungen über eine eigeneratige organische Erkrangkung des Zentralnervensystems in Praesenium. Zeitschrift für die gest Neurologie und Psychiatrie, 118, 49-114.
63. Heston L, Lowther D and Leventhal C (1966) Alzheimer's disease. A family study. Archives of Neurology, 15, 225-233.
64. Hsiao K, Baker H, Crow T, Poulter M, Owen F, Terwilliger J, Westaway D, Ott J and Prusiner S (1989) Linkage of a prion protein missense variant to Gerstmann-Sträussler syndrome. Nature, 338, 342-345.
65. Hsiao K, Dlouhy S, Farlow M, Cass C, Da Costa M, Conneally M, Hodes M, Ghetti B and Prusiner S (1992) Mutant prion proteins in Gerstmann-Strèussler-Scheinker disease with neurofibrillary tangles. Nature Genetics, 1, 68-71.
66. Ikeda S, Yanagisawa N, Allsop D and Glenner G (1991) A variant of Gerstmann-Strèussler-Scheinker disease with β-protein epitopes and dystrophic neuntes in the peripheral region of PrP-immunoreactive amyloid plaques. In: Amyloid and Amyloidosis, (Eds JB Natvig, O Forre, OG Husby, A Husebeck, B Skogen, K Sletten, P Westermark) pp. 737-740. Dordrecht, Kluwer Academic.
67. Julien J, Vital C, Delepanque B, Lagueny A and Ferrer X (1990) Atrophie thalamique subaiguë familiale. Troubles mnésiques et insomnie totale. Revue Neurologique (Paris), 146, 173-178.
68. Kirschbaum W (1968) Jakobi-Creutzfeldt Disease. New York, Elsevier.
69. Kitamoto T, Tateishi J, Tashima T, Takeshita I, Barry R, DeArmond S and Prusiner S (1986) Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibody. Annals of Neurology, 20, 204-208.
70. Kitamoto T, Amano N, Terao Y, Nakazato Y, Isshiki T, Mizutani T and Tateishi J (1993) A new inherited prion disease (PrP-P105L mutation) showing spastic paraparesis. Annals of Neurology, 34, 808-813.
71. Kitamono T, Doh-ura K, Muramoto T, Miyazono M and Tateishi J (1992) The primary structure of the prion protein influences the distribution of abnormal prion protein in the central nervous system. Americal Journal of Pathology, 141, 271-277.
72. Kretzschmar HA, Kitamoto T, Doerr-Schott J, Mehraein P and Tateishi J (1992) Diffuse deposition of immunohistochemically labeled prion protein in the granular layer of the cerebellum in a patient with Creutzfeldt-Jakob disease. Acta Neuropathologica (Berlin), 82, 536-540.
73. Lafarga M, Berciano MT, Suarez I, Viadero CF, Andres MA and Berciano J (1991) Cytology and organization of reactive astroglia in human cerebellar cortex with severe loss of granule cells: a study on the ataxic form of Creutzfeldt-Jakob disease. Neuroscience, 40, 337-352.
74. Lampert P, Gajdusek DC and Gibbs CJJ (1972) Subacute spongiform virus encephalopathies: kuru and Creutzfeldt-Jakob disease. American Journal of Pathology, 68, 626-646.
75. Lantos P (1992a) From slow virus to prion: a review of transmissible spongiform encephalopathy. Histopathology, 20, 1-11.
76. Lantos P (1992b) Overview of neuropathology. In: Unusual Dementias. London, Baillière Tindall.
77. Laplanche JL, Delasnerie-Lauprètre N, Brandel JP, Chatelain J, Beaudry P, Alpérovitch A and Launay J-M (1994) Molecular genetics of prion diseases in France. Neurology, 44, 2347-2351.
78. Lasmézas CI, Deslys JP, Demalmay R, Adjou KT, Lamoury f, Dormont D, Robain O, Ironside J and Hauw JJ (1996) BSE transmission to macaque. Nature, 381, 743-744.
79. Liberski P (1996) Tubulovesicular structures are not composed of prion protein (PrP) and are not related to scrapie-associated fibrils (SAF). Third International Symposium on Transmissible Subacute Spongiform Encephalopathies: Prion Diseases, Paris Val de Grace.
80. Liberski P, Budka H, Sluga E, Barcikowska M and Kwiecinshi H (1992) Tubulovesicular structures in Creutzfeldt-Jakob disease. Acta Neuropathologica (Berlin), 84, 238-243.
81. Liberski PP, Yanagihara R, Gibbs CJ and Gajdusek DC (1989) White matter ultrastructural pathology of experimental Creutzfeldt-Jakob disease in mice. Acta Neuropathologica, 79, 1-9.
82. Lugaresi R, Medori R, Montagna P, Baruzzi A, Cortelli P, Lugaresi A, Tinuper P, Zucconi M and Gambetti P (1986) Fatal familial insomnia and dysautonomia with selective degeneration of thalamic nuclei. New England Journal of Medicine, 315, 997-1003.
83. Macchi G, Abbamondi AL, Arnetoli G and Toscani L (1986) On the diffuse degeneration of the thalamus and the striatum. Clinico-pathological study of a case. Tenth International Congress of Neuropathology, Stockholm.
84. Manetto V, Medori R, Cortelli P, Montagna P, Tuniper P, Baruzzi A, Rancurel G, Hauw JJ, Vanderghagen JJ, Mailleux P, Bugiani O, Tagliavini F, Bouras C, Rizzuto N, Lugarisi E and Gambetti P (1992) Fatal familial insomnia: clinical and pathological study of five new cases. Neurology, 42, 312-319.
85. Martinez-Lage F, Poza M, Sola J, Tortosa J, Brown P, Cervenakova L, Esteban J and Mendoza A (1994) Accidental transmission of Creutzfeldt-Jakob disease by durai cadaveric graft. Journal of Neurology, Neurosurgery and Psychiatry, 57, 1091-1094.
86. Masters CL and Richardson EP Jr (1978) Subacute spongiform encephalopathy (Creutzfeldt-Jakob disease). The nature and progression of spongiform change. Brain, 101, 333-344..
87. Masters CL and Beyreuter K (1988) Neuropathology of unconventional virus infections: molecular pathology of spongiform change and amyloid plaque deposition. Novel infectious agents and the central nervous system, Ciba Foundation Symposium 135, pp. 24-36. Chichester, Wiley.
88. Masters CL, Harris JO, Gajdusek DC, Gibbs CJJ, Bernoulli C and Asher DM (1979) Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Annals of Neurology, 5, 177-188.
89. McGeer P, Kawamata T, Walker D, Akiyama H, Tooyama I and McGeer E (1993) Microglia in degenerative neurological diseases. Glia, 7, 84-92.
90. Medori R (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. New England Journal of Medicine, 326, 444-449.
91. Mendez M, Mastri A, Sung J and Frey WI (1992) Clinically diagnosed Alzheimer disease: neuropathologic findings in 650 cases. Alzheimer Disease and Association Disorders, 6, 35-43.
92. Mertz P, Rohwer R, Somerville R, Gibbs CJ and Gajdusek DC (1984) Infection specific particle from the unconventional slow virus disease. Science, 225(4), 37-40.
93. Miller DC (1988) Creutzfeldt-Jakob disease in histopathology technicians. New England Journal of Medicine, 318, 853-854.
94. Miyazono M, Kitamono T, Doh-ura K, Iwaki T and Tateishi J (1992a) Creutzfeldt-Jakob disease with codon 129 polymorphism (Valine): a comparative study of patients with codon 102 point mutation or without mutations. Acta Neuropotholgica (Berlin), 84, 349-354.
95. Miyazono M, Kitamoto T, Iwaki T and Tateishi J (1992b) Colocalisation of prion protein and β protein in the sale amyloid plaques of patients with Gerstmann-Sträussler syndrome. Acta Neuropathologica (Berlin), 83, 333-339.
96. Mizutani Y, Okumura A, Oda M and Shiraki H (1981) Panencephalopathic type of Creutzfeldt-Jakob disease. Journal of Neurology, Neurosurgery and Psychiatry, 44, 103-115.
97. Mohr M, Tranchant C, Heldt N and Walter JM (1995) Alsatian variant of codon 117 form of Gerstmann-Sträussler-Scheinker syndrome: autopsic study of 3 cases. Brain Pathology, 4, 524.
98. Mühleisen H, Gehrmann J and Meyermann R (1995) Reactive microglia in Creutzfeldt-Jakob disease. Neuropathology and Applied Neurobiology, 21, 505-517.
99. Namba Y, Tomonoga M, Kawasaki H, Otomo E and Ikeda K (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Research, 541, 163-166.
100. New MI, Brown P, Temek JW, Owensm AB, Hedley-White ET and Richardson EP (1988) Preclinical Creutzfeldt-Jakob disease discovered at autopsy in a human growth hormone recipient. Neurology, 38, 1133-1134.
101. Nochlin D, Sumi S, Bird T, Snow A, Leventhal C, Beyreuter K and Masters C (1989) Familial dementia with PrP-positive amyloid plaques. A variant of Gersmann-Sträussler syndrome. Neurology, 39, 910-918.
102. Otto V, Patzold U, Donhuijsen K and Walter G (1995) Severe cerebellar atrophy in the panencephalopathic type of Creutzfeldt-Jakob disease: a case report. Journal of Neurology, 242, 348-353.
103. Ozel M and Diringer H (1994) Small virus-like structure in fractions from scrapie hamster brain. Lancet, 343, 894-895.
104. Ozel M, Xi YG, Baldauf E, Diringer H and Pocchiari M (1994) Small virus-like structure in brains from cases of sporadic and familial Creutzfeldt-Jakob disease. Lancet, 344, 923-924.
105. Palmer M, Dryden A, Hughes J and Collinge J (1991) Homozygous prion protein genotype predisposed to sporadic Creutzfeldt-Jakob disease. Nature, 352, 340-342.
106. Petersen R, Tabaton M, Chen SG, Monari L, Richardson SC, Lynches T, Manetto V, Lanska DJ, Markesbery WR, Currier RD, Autilio-Gambetti L, Wilhelmsen KC, Gambetti P (1995) Familial progressive subcortical gliosis: Presence of prions and linkage to chromosome 17, Neurology, 45, 1062-1065.
107. Powers JM, Liu Y, Hair LS, Kascsack RJ, Lewis LD and Levy LA (1991) Concomitant Creutzfeldt-Jakob and Alzheimer diseases. Acta Neuropathologica (Berlin), 83, 95-98.
108. Prusiner S (1996) Human Prion diseases and neurodegeneration. In: Prions, Prions, Prions (Ed SB Prusiner). Berlin, Springer.
109. Prusiner SB, Bolton DC, Groth DF, Bowman KA, Cochran SP and McKinley MP (1982) Further purification and characterization of scrapie prions. Biochemistry, 21, 6942-6950.
110. Ribadeau-Dumas JL and Escourolle R (1974) The Creutzfeldt-Jakob syndrome. A neuropathological and electron microscopic study. Neurology Proceedings, Tenth International Conference, pp. 315-324. Amsterdam, Excerpta Medica.
111. Richardson E and Masters C (1995) The nosology of Creutzfeldt-Jakob disease and conditions related to the accumulation of PrPCJD in the nervous system. Brain Pathology, 5, 33-41.
112. Ridley R and Baker H (1993) Prion protein: a different concept of replication. Trends in Neurosciences, 16, 435-426.
113. Rondot P, Fallet-Bianco C and Guegen B (1986) Gerstmann-Sträussler-Scheinker (G.S.S.)'s disease. In: Unconventional Virus Diseases of the Central Nervous System (Eds L Court, D Dormont, P Brown and DT Kingsbury), pp. 142-145. Fontenay-aux-Roses, CEA.
114. Rüssel R (1980) Supranuclear palsy of eyelid closure. Brain, 71-78.
115. Salazar AM, Masters CL, Gajdusek DC and Gibbs CJ Jr (1983) Syndromes of amyotrophic lateral sclerosis and dementia: relation to transmissible Creutzfeldt-Jakob disease. Annals of Neurology, 14, 17-26.
116. Schlote W, Boellaard JW, Schumm F and Stohr M (1980) Gerstmann-Sträussler-Scheinker's disease. Acta Neuropathologica, 52, 203-211.
117. Schoene W, Masters C, Gibbs C, Gajdusek D, Tyler R, Moore F and Dammin G (1981) Transmissible spongiform encephalopathy (Creutzfeldt-Jakob disease) Atypical clinical and pathological findings. Archives of Neurology, 38, 473-477.
118. Seilhean D, Rancurel G, Garma L, Lugaresi E, Gambetti P and Hauw J-J (1993) Fatal familial insomnia: neuropathological study. Fatal Familial Insomnia: Inherited Prion Diseases, Sleep and the Thalamus (Eds C Guilleminault, E Lugaresi, P Montana, P Gambetti) New York, 33-36, New York, Raven Press.
119. Sigurdsson B (1954) Rida, a chronic encephalitis of sheep with general remarks on infections which develop slowly and some of their special characteristics. British Veterinary Journal, 110, 341-354.
120. Tagliavini F, Prelli F, Ghisto J, Bugiani O, Serban D, Prusiner S, Farlow M, Ghetti B and Frangione B (1991) Amyloid protein of Gerstmann-Sträussler-Scheinker disease (Indiana kindred) is an 11-kd fragment of prion protein with an N-terminal glycin at codon 58. EMBO Journal, 10, 513-519.
121. Tateishi J, Sato Y and Ohta M, (Eds) (1983) Creutzfeldt-Jakob disease in humans and laboratory animals. In: Progress in Neuropathology, (Ed HM Zimmerman) 5, pp 195-221, New York, Raven Press.
122. Tomlinson BE (1992) Ageing and the dementias. In: Greenfied's Neuropathology, 5th Edn, pp. 1284-1410. London, Edward Arnold.
123. Tsuji S and Kuroyawa Y (1983) Creutzfeldt-Jakob disease in Japan. Neurology, 33, 1503-1506.
124. Warter J, Steinmetz G, Heldt N, Rumbach L, Marescaux C, Eber A, Collard M, Rohmer F, Floquet J, Guedenet J, Gehin P and Weber M (1982) Démence présénile familiale. Syndrome de Gerstmann-Sträussler-Scheinker. Revue Neurologique (Paris), 138, 107-121.
125. Watanabe R and Duchen LW (1993) Cerebral amyloid in human prion disease. Neuropathology and Applied Neurobiology, 19, 253-260.
126. Weber T, Tumani H, Holdorff B, Collinge J, Palmer M, Kretzschmar A and Felgenhauer K (1993) Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet, 341, 123-124.
127. Will R and Matthews W (1984) A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-1979: 1 Clinical features. Journal of Neurology, Neurosurgery and Psychiatry, 47, 134-140.
128. Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeira K, Alpérovitch A, Poser S, Pocciari M, Hofman A and Smith PG (1996) A new variant of Creutzfeldt-Jakob disease in the UK. Lancet, 347, 921-925.